Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings.

PURPOSE Adjuvant radiation therapy (RT) for breast cancer improves outcomes, but prior studies have documented substantive cardiac dose and cardiac risk. We assessed the mean heart dose (MHD) of RT and estimated the risk of RT-associated cardiac toxicity in women undergoing adjuvant RT for breast cancer in contemporary (predominantly) community practice. METHODS AND MATERIALS We identified women with left-sided breast cancer receiving adjuvant RT between 2012 and 2014 from 94 centers across 16 states. We used bivariate analyses and multivariable linear regression to assess associations between RT techniques and MHD. Excess RT-related cardiac risk by age 80 was estimated for women diagnosed at age 60 using the previously reported relationship between MHD and cardiac risk. RESULTS Among 1161 women, 77.3% were treated in community practice and with breast conservation (77.8%). The most common techniques were free-breathing (92.2%), supine (94.8%), and fixed gantry intensity modulated RT (FG-IMRT; 46.9%). The median MHD was 2.76 Gy (interquartile range, 1.47-5.03). In multivariable analyses, the predicted median MHD with deep inspiration breath hold was 2.41 Gy compared with 3.86 Gy with free-breathing (P < .001). Three-dimensional conformal RT (3D-CRT) was associated with a lower predicted median MHD (2.78 Gy) than FG-IMRT (4.02 Gy) or rotational IMRT, 6.60 Gy, P < .001). For 60-year-old women with the median MHD of the study population (2.76 Gy) and no cardiovascular risk factors, the 20-year predicted excess risk of death from ischemic heart disease attributable to radiation was 3.5 excess events/1000 patients, in contrast to estimates of 8 events/1000 from prior analyses. The predicted risk of cardiac events varied based on radiation technique, with 4 excess events/1000 with 3D-CRT, 5 excess events/1000 with FG-IMRT, and 8 excess events/1000 with rotational IMRT. CONCLUSIONS MHD varies substantially across patients and is influenced by technique in predominantly community settings. Overall risk of cardiac toxicity is modest.

[1]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[2]  Bhudatt R Paliwal,et al.  Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  Gabor Jozsef,et al.  Prone vs supine positioning for breast cancer radiotherapy. , 2012, JAMA.

[4]  W. Woodward,et al.  Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. , 2007, International journal of radiation oncology, biology, physics.

[5]  A. Niemierko,et al.  Deep inspiration breath-hold technique in left-sided breast cancer radiation therapy: Evaluating cardiac contact distance as a predictor of cardiac exposure for patient selection. , 2015, Practical radiation oncology.

[6]  Wayne Beckham,et al.  A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  L. Price,et al.  Dose-modeling study to compare external beam techniques from protocol NSABP B-39/RTOG 0413 for patients with highly unfavorable cardiac anatomy. , 2006, International journal of radiation oncology, biology, physics.

[8]  T. Rosewall,et al.  Anatomic features of interest in women at risk of cardiac exposure from whole breast radiotherapy. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  A. Paravati,et al.  Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer. , 2015, International journal of radiation oncology, biology, physics.

[10]  Zuofeng Li,et al.  Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons. , 2016, International journal of radiation oncology, biology, physics.

[11]  Xiaoli Tang,et al.  Utility of Deep Inspiration Breath Hold for Left-Sided Breast Radiation Therapy in Preventing Early Cardiac Perfusion Defects: A Prospective Study. , 2017, International journal of radiation oncology, biology, physics.

[12]  L. Marks,et al.  Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? , 2006 .

[13]  R. Peto,et al.  Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. , 2005, The Lancet. Oncology.

[14]  Zhe Wang,et al.  Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013. , 2015, International journal of radiation oncology, biology, physics.

[15]  S. Evans,et al.  Breast cancer laterality does not influence survival in a large modern cohort: implications for radiation-related cardiac mortality. , 2014, International journal of radiation oncology, biology, physics.

[16]  B. Kavanagh,et al.  Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy. , 2014, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[17]  J. Goodwin,et al.  Cardiac morbidity of adjuvant radiotherapy for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Wu,et al.  A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT , 2015, Radiation Oncology.

[19]  A. Petoukhova,et al.  Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further? , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  P. Hall,et al.  Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.

[21]  M. Little,et al.  Analysis of dose response for circulatory disease after radiotherapy for benign disease. , 2012, International journal of radiation oncology, biology, physics.

[22]  K. Zedeler,et al.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. , 1997, The New England journal of medicine.

[23]  Michael Hauptmann,et al.  Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  D. Mele,et al.  Cancer therapy-induced cardiotoxicity: role of ultrasound deformation imaging as an aid to early diagnosis. , 2015, Ultrasound in medicine & biology.